Fact-checked by Grok 2 weeks ago

Prodigiosin

Prodigiosin is a naturally occurring red-pigmented belonging to the prodiginine family of secondary metabolites, primarily produced by such as . This tripyrrole , with the molecular C₂₀H₂₅N₃O and a molecular weight of 323.43 g/mol, exhibits a characteristic crimson hue, making it a notable in microbial ecology and . First isolated in pure form in , prodigiosin has garnered significant attention for its multifaceted bioactivities, including potent , anticancer, and immunosuppressive properties, positioning it as a promising candidate for therapeutic and industrial applications. Chemically, prodigiosin features a linear tripyrrole scaffold composed of three rings: ring A (a simple ), ring B (a 3-methoxypyrrole), and ring C (a 2-methyl-3-n-pentyl), which contributes to its stability and bioactivity. Its occurs via a dedicated involving the condensation of 2-methyl-3-n-amylpyrrole (MAP) and 4-methoxy-2,2'-bipyrrol-5-carbaldehyde (MBC), regulated by 14 genes such as pigA through pigN in producer organisms like . Production is influenced by environmental factors like signals (e.g., autoinducer-1 and -2), , and nutrient availability, with yields optimized through or media supplementation in species like and spp.. Beyond , prodigiosin analogs are synthesized by actinomycetes and vibrios, highlighting its evolutionary conservation across microbial taxa. The biological activities of prodigiosin are diverse and concentration-dependent, with low doses often promoting while higher doses induce in target cells. It demonstrates broad-spectrum effects against Gram-positive and , such as Staphylococcus aureus and Escherichia coli, with minimum inhibitory concentrations ranging from 0.006 to 100 μg/mL, attributed to membrane disruption and DNA intercalation. In , prodigiosin inhibits proliferation in models of , , and cancers by modulating pathways like Wnt/β-catenin signaling and inducing copper-dependent , with IC₅₀ values as low as 0.116 μM. Additional properties include activity (IC₅₀ of 3.65–4.13 μg/mL in DPPH/ABTS assays), anti-algal effects against harmful blooms, and larvicidal action against insect larvae and protozoans, underscoring its ecological role in microbial competition. Research on prodigiosin emphasizes its potential in , where it serves as a lead for novel antibiotics and chemotherapeutics resistant to conventional treatments. In non-pharmaceutical contexts, its vibrant color and stability position it as a for textiles, food additives, and UV protectants, with values exceeding 30 in formulations. Ongoing studies as of 2024 focus on sustainable production via optimization and to enhance yields exceeding 1000 mg/L, addressing scalability challenges for commercial use. Despite its promise, toxicity concerns at higher doses necessitate further pharmacokinetic investigations to ensure safe clinical translation.

Introduction and History

Discovery and Etymology

The red pigment prodigiosin was first observed in 1819 by Italian pharmacist and chemist Bartolomeo Bizio during an investigation of bloody discoloration in a batch of (cornmeal mush) in the town of Legnaro near , . Bizio attributed the phenomenon to a newly identified , initially classified as a fungus and later named in 1823, honoring the Italian physicist and inventor Serafino Serrati (also known as ) and using the Latin marcescens to denote its decaying properties, referring to the fading of the red pigment over time. This marked the initial scientific recognition of the pigment as a bacterial product, though its chemical nature remained unexplored for over a century. The pigment was first extracted from bacterial cultures and named "prodigiosin" in 1902 by German chemist August Kraft, who isolated it from Bacillus prodigiosus (an earlier designation for S. marcescens). The name derives from the Latin prodigium, meaning an extraordinary event, omen, or marvel, chosen to capture the pigment's intense blood-red hue and its longstanding cultural associations with miraculous or occurrences, such as bleeding statues or Eucharistic hosts. Early 20th-century research, including work by microbiologists like Rudolf Emmerich and colleagues in the , linked prodigiosin production to bacterial pigmentation patterns, demonstrating its dependence on environmental factors like and media composition, but without chemical characterization. Pure isolation of prodigiosin was achieved in 1929 by Friedrich Wrede and Otto Hettche at the , who obtained the compound in crystalline form from S. marcescens and reported its basic properties, such as solubility and stability. Building on this, Harry H. Wasserman and coworkers advanced its study in the mid-20th century; in 1956, they detailed spectral and chromatographic characteristics that confirmed its identity as a distinct , paving the way for structural elucidation in the early through partial synthesis. These efforts established prodigiosin as a prototypical bacterial , distinct from porphyrins despite superficial similarities in color and .

Cultural and Religious Significance

Prodigiosin, the vibrant red pigment produced by bacteria such as , is hypothesized to have been linked to apparent miracles involving "bleeding" Eucharistic hosts in medieval , where growth of the bacterium on damp bread or wafers may have mimicked bloodstains and was interpreted as divine intervention. A prominent example is the 1263 Miracle of Bolsena in , during which a reportedly observed blood emerging from the host during at the Church of Santa Cristina, an event that reinforced Catholic doctrine on and prompted to institute the Feast of in 1264. Similar incidents have been documented in numerous historical accounts from the onward, often occurring under humid conditions favorable to S. marcescens proliferation on starchy substrates. In , prodigiosin-tainted substances were viewed as omens or supernatural signs across various cultures, particularly in where red spots on or were sometimes deemed diabolical portents by local communities. These interpretations extended to broader symbolic roles, such as ancient accounts from 332 BCE where Macedonian soldiers linked the pigment's appearance to divine favor in battle, influencing perceptions of prodigiosin as a harbinger of fate. Modern microbiology has explained these phenomena as microbial contamination by Serratia marcescens, first identified by Bartolomeo Bizio in 1819 in Legnaro near , , with prodigiosin's red hue resulting from its tripyrrole structure rather than blood. Despite this, the cultural legacy persists in art and literature; for instance, Raphael's 1512 fresco The Mass at Bolsena in the Vatican's Stanza della Segnatura immortalizes the event, while literary works continue to evoke prodigiosin-inspired motifs as symbols of mystery and faith.

Chemical Structure and Properties

Molecular Structure

Prodigiosin is classified as a linear tripyrrole alkaloid, characterized by its molecular formula C_{20}H_{25}N_{3}O and a molecular weight of 323.43 g/mol. This structure was first elucidated in the early 1960s through partial and total chemical synthesis, confirming its arrangement as a conjugated system derived from three pyrrole units. The core architecture of prodigiosin features a pyrrolylpyrromethene , consisting of a central pyrromethene unit linked to terminal rings via methine bridges, which imparts extensive π-conjugation across the molecule. A is attached at the C-7 position on the central ring, while an alkyl —specifically an n-pentyl group—is substituted at the C-4 position of one terminal pyrrole ring, with a at the C-5 position. This configuration results in no chiral centers, rendering the molecule achiral, and the extended conjugation promotes a planar that stabilizes the and contributes to its characteristic red pigmentation. In comparison to other prodiginines, prodigiosin is distinguished by its relatively short pentyl side chain, whereas undecylprodigiosin incorporates a longer undecyl (C_{11}) chain at the equivalent position, altering lipophilicity and potentially biological interactions without changing the core tripyrrole framework.

Physical and Chemical Properties

Prodigiosin is a bright red pigment attributed to its extended conjugation within the tripyrrole core structure. This coloration is most pronounced in acidic conditions, where it exhibits a sharp absorption maximum at 535 nm, as observed in methanol or acidic ethanol solutions. In alkaline environments, the absorption shifts to a broader peak centered around 470 nm, resulting in an orange-yellow hue. Prodigiosin demonstrates low solubility in water, rendering it effectively insoluble under neutral conditions, but it is highly soluble in various organic solvents, including chloroform, methanol, ethanol, acetonitrile, and dimethyl sulfoxide. Its solubility in aqueous media is pH-dependent; the neutral form predominates in basic conditions, limiting dissolution, while protonation in acidic environments forms a cationic species that may slightly enhance water solubility. The compound exhibits sensitivity to environmental factors, degrading upon exposure to or UV radiation, which complicates its use in applications requiring prolonged illumination. It is also pH-labile, with optimal observed at neutral to slightly alkaline (7–9), whereas extreme acidity or basicity leads to color fading and structural instability. Prodigiosin acts as a , with a value of approximately 7.65 for the nitrogen, enabling salt formation with acids such as to yield stable protonated derivatives. It lacks significant , consistent with a predicted exceeding 550°C.

Occurrence and Biosynthesis

Natural Microbial Producers

Prodigiosin is primarily produced by the Gram-negative bacterium , a member of the Gamma-Proteobacteria, which is ubiquitous in diverse environments including , freshwater, marine waters, and human-associated settings such as medical devices and the . This opportunistic and environmental microbe synthesizes prodigiosin as a , often contributing to its characteristic red pigmentation. Other notable natural producers include actinomycetes such as various species (e.g., S. coelicolor and S. griseoviridis), as well as Gram-negative bacteria from genera like (e.g., V. psychroerythrus and V. spartinae), Pseudomonas (e.g., P. magnesiorubra), Alteromonas (e.g., A. rubra), and marine species such as Pseudoalteromonas (e.g., P. rubra) and Hahella chejuensis. These organisms span both terrestrial and aquatic niches, with Streptomyces predominantly found in soil and Vibrio and Pseudoalteromonas species thriving in marine ecosystems. Prodigiosin-producing bacteria are distributed across terrestrial soils, freshwater bodies, coastal marine habitats, and even extreme environments like cold Alaskan soils, where production aids in ecological competition and adaptation. Yields are often elevated in biofilms, where dense microbial communities form on surfaces, or under stress conditions such as nutrient limitation, enhancing the pigment's role in antimicrobial defense. Production is influenced by several environmental factors, including temperature, with optimal synthesis occurring between 25°C and 30°C for S. marcescens, while higher temperatures (e.g., 37°C) repress it due to thermoregulatory mechanisms. Nutrient availability plays a key role, as high inorganic phosphate concentrations (above 0.4 mM) repress prodigiosin biosynthesis in producers like Vibrio gazogenes and Serratia species, whereas suboptimal phosphate levels promote it. Additionally, quorum sensing, mediated by autoinducers such as N-acyl homoserine lactones in Serratia, coordinates production in response to population density, linking it to communal behaviors like biofilm formation.

Biosynthetic Pathway

The biosynthetic pathway of prodigiosin in producing bacteria, such as species, is encoded by the , which spans approximately 25 kb and consists of 14 to 15 genes (pigA to pigN in ATCC 274, or pigA to pigO in Serratia sp. ATCC 39006). These genes encode a combination of synthases, non-ribosomal synthetases, and accessory enzymes that assemble the tripyrrole from simple precursors like , serine, and fatty acids. In species, a homologous gene cluster directs the synthesis of related prodiginines, such as undecylprodigiosin, with variations in chain length. The pathway proceeds through two convergent branches: the synthesis of 4-methoxy-2,2'-bipyrrole-5-carbaldehyde (MBC) from L-proline and the synthesis of 2-methyl-3-n-amyl-pyrrole () from pyruvate and 2-octenal. MBC begins with activation of L-proline by PigI, a prolyl-AMP , followed by transfer to PigG, a peptidyl carrier protein (), and successive oxidations by PigA, an NADPH-dependent , to form a pyrrole-2-carboxyl unit. This unit is then extended by PigJ, a β-ketoacyl , using , and condensed with serine-derived units by PigH to yield 4-hydroxy-2,2'-bipyrrole-5-methanol (HBM), which is oxidized by PigM to 4-hydroxy-2,2'-bipyrrole-5-carbaldehyde (HBC). The final step in this branch involves methylation of HBC by PigF, an O-methyltransferase, to produce MBC. Meanwhile, MAP formation starts with PigD, which decarboxylates pyruvate and condenses it with 2-octenal to form 3-acetyloctanal, followed by by PigE to yield the intermediate, and oxidation by PigB to MAP. The prodiginine core is assembled by PigC, the terminal condensing enzyme, which couples MBC and in an ATP-dependent reaction to form prodigiosin. Accessory enzymes like PigL, a phosphopantetheinyl , activate ACP domains in PigG and PigH, while PigN contributes to late-stage modifications, though its precise role remains under investigation. The entire pig cluster is transcribed as a single polycistronic mRNA, with expression regulated by systems, including the LuxS-dependent autoinducer-2 (AI-2) pathway that coordinates production at high cell densities. Variations in the pathway occur across species, particularly in marine producers like Hahella chejuensis or Pseudoalteromonas rubra, where modifications in the MAP branch lead to prodiginine analogs with extended alkyl chains (e.g., propyl to octyl substituents instead of the standard pentyl in Serratia prodigiosin). In Streptomyces coelicolor, the red cluster produces longer-chain variants like undecylprodigiosin through extended elongation.

Production Methods

Laboratory Synthesis

Laboratory synthesis of prodigiosin encompasses both total chemical synthesis routes and microbial fermentation methods using natural producers like Serratia marcescens. Early efforts focused on elucidating the structure through partial synthesis, while later developments achieved complete total syntheses and scalable production techniques. The first partial synthesis of prodigiosin was reported in 1960 by Wasserman et al., involving the coupling of a derivative with a methene bridge to mimic the tripyrrolic core, confirming key structural features of the molecule. A full was accomplished in 1989 by Wasserman and Lombardo, utilizing vicinal tricarbonyl compounds to form the 3-hydroxypyrrole unit via addition, followed by assembly of the pyrrolylpyrromethene skeleton through and cyclization steps. This approach highlighted the reactivity of tricarbonyls in building the characteristic red pigment's framework, though overall yields remained modest due to the multi-step nature of pyrrole manipulations. Modern chemical syntheses have employed palladium-catalyzed cross-coupling reactions for efficient tripyrrole assembly. For instance, the 2000 total synthesis of a cyclic prodigiosin analog by Fürstner et al. utilized a between a and an iodopyrrole intermediate, achieving the key C-C bond formation in good before final deprotection and macrocyclization. Similar strategies have been applied to linear prodigiosins, such as undecylprodigiosin, where of a boronate with a halopyrrole afforded the product in 73% for that step. These methods offer improved modularity for analog synthesis but still face challenges in scaling due to the instability of intermediates and the need for protecting groups. In laboratory settings, prodigiosin is commonly produced via submerged of in or shake flasks, optimizing media components for higher titers. serves as an effective carbon source, with studies showing yields of approximately 300 mg/L in peptone-glycerol broth after 48-72 hours at 28-30°C and 7. Typical unoptimized s yield 100-500 mg/L, limited by availability and oxygen transfer, while modern systems with controlled can reach several grams per liter through and temperature adjustments. Purification from fermentation broth involves acidifying the culture to pH 3 to protonate the pigment, followed by extraction with or , and subsequent using hexane-ethyl acetate gradients. This process achieves high purity but is hindered by prodigiosin's and low in aqueous media, necessitating dark conditions and organic solvents. Early historical methods relied on simple solvent extraction from plate cultures, yielding milligrams per liter, whereas current scalable fermenters enable gram-scale for applications.

Optimization and Engineering Strategies

Optimization of prodigiosin production has focused on enhancing yields through refined culturing conditions and genetic modifications in producer strains such as . (RSM) has been widely applied to optimize parameters, including , temperature, and media composition. For instance, using RSM with peanut oil seed cake as a supplement, optimal conditions of 7.5, 28°C, and 72-hour yielded 3.5 g/L prodigiosin, representing an 11.67-fold increase over unoptimized basal medium. Genetic engineering strategies target the pig biosynthetic gene cluster to boost expression and alleviate repression. Overexpression of the pig cluster via plasmids in heterologous hosts like Escherichia coli enables prodigiosin synthesis, though yields remain modest due to folding and pathway inefficiencies. In native S. marcescens, plasmid-based overexpression combined with regulator tuning has achieved titers exceeding 2 g/L. Knockout of repressors, such as the LysR-type HexS, derepresses the pig under glucose-rich conditions, leading to elevated prodigiosin levels by preventing catabolite inhibition. Post-2020 advances in have emphasized pathway refactoring and co-expression systems to improve flux and stability. Promoter engineering upstream of the pig cluster, coupled with modifications like OmpR overexpression, has refactored the pathway for enhanced activation, resulting in prodigiosin yields up to 10.25 g/L in engineered S. marcescens—a 1.62-fold improvement over wild-type strains. Bioreactor-based batch strategies have further scaled production, achieving an 8-fold increase in yield per (293.1 mg/L prodigiosin) by mitigating inhibition and oxygen limitations. Sustainability efforts leverage agro-industrial wastes to lower costs and environmental impact. Supplementation with inexpensive substrates like as a carbon source supports robust growth and prodigiosin biosynthesis, enabling cost-effective titers comparable to while reducing reliance on refined sugars. Similarly, seed cake from oil processing wastes serves as a nutrient-rich additive, promoting 3- to 5-fold yield enhancements in optimized fermentations without compromising purity. Recent approaches (as of 2023) include using rice straw-derived hydrolysate supplemented with de-oiled cake, achieving yields up to 6.1 g/L under optimized conditions ( 6.5, 28°C, 72 hours), highlighting eco-friendly scaling for industrial use.

Biological Activities

Antimicrobial Effects

Prodigiosin exhibits broad-spectrum antibacterial activity, particularly against such as , with minimum inhibitory concentrations () ranging from 1 to 5 μg/mL and inhibition zones of approximately 35 mm. It is also effective against other strains like (inhibition zone 22 mm), though activity against , such as ( 25 μg/mL), is generally weaker due to the outer membrane barrier. This selective potency highlights prodigiosin's potential as an alternative to conventional antibiotics, especially in combating resistant strains like methicillin-resistant S. aureus ( as low as 2.5 μg/mL). In addition to antibacterial effects, prodigiosin demonstrates notable antifungal properties against pathogens including , where it reduces growth by 30% at concentrations as low as 0.3 μg/mL, and (MIC 10 μg/mL). It inhibits at an MIC of 8 μg/mL and shows synergy with chitinases to suppress germ tube formation in Mycosphaerella fijiensis by 50% at 996 μg/mL. These activities position prodigiosin as a candidate for managing fungal infections, surpassing some traditional antifungals in potency against certain strains. Prodigiosin also possesses activity, notably against , with IC50 values between 1.7 and 8.0 nM, suggesting its viability for antimalarial development. It targets other protozoa like (IC50 lower than ) and metronidazole-resistant through mitochondrial dysfunction and induction. The antimicrobial mechanism of prodigiosin primarily involves its role as a protonated ionophore facilitating H+/Cl- symport across microbial membranes, leading to intracellular pH imbalance, membrane depolarization, and plasma membrane damage via hydrophobic interactions. This process triggers oxidative stress through reactive oxygen species (ROS) generation, as observed in Pseudomonas aeruginosa, and induces apoptosis-like responses, with up to 70% of treated E. coli cells showing Annexin V positivity. Such multifaceted actions underscore prodigiosin's disruption of essential cellular homeostasis in microbes.

Anticancer and Immunosuppressive Activities

Prodigiosin exhibits potent anticancer activity primarily through the induction of in various malignant cell lines, including those from , , and colon cancers. In (CLL) cells, it triggers caspase-dependent with an of approximately 116 , selectively targeting malignant B and T cells while sparing normal lymphocytes. Similarly, in cell lines such as , prodigiosin inhibits proliferation and promotes with an around 62-4000 , depending on exposure duration and status. For colon cancer, notably SW-620 cells, it shows high sensitivity with an of 273 , leading to DNA fragmentation and condensed nuclei characteristic of . These effects are observed across a broad range of values (50-300 typically), highlighting its efficacy at nanomolar concentrations without significant toxicity to non-cancerous cells. The mechanisms underlying prodigiosin's anticancer effects involve multiple pathways. It binds to DNA via intercalation, preferentially at alternating purine-pyrimidine sequences, and inhibits topoisomerase II, causing DNA strand breaks and cell-cycle arrest in G2/M phase. Copper-mediated oxidative damage plays a key role, as prodigiosin facilitates (ROS) generation, which activates caspase-3 and -9, amplifying mitochondrial . Additionally, its pH-dependent activity as an H+/Cl- disrupts lysosomal acidification in tumor cells, leading to lysosomal membrane permeabilization and release of cathepsins that further promote caspase activation. This selective lysosomal targeting exploits the acidic environment of cancer cells, enhancing while minimizing effects on normal cells. Prodigiosin also demonstrates immunosuppressive properties by inhibiting T-cell proliferation and activation, with an IC50 of about 100-116 nM in primary T cells. It suppresses interleukin-2 (IL-2) production and downregulates IL-2 receptor alpha (IL-2Rα) expression, blocking IL-2-dependent signaling pathways such as JAK/STAT and , which are essential for T-cell expansion. This T-cell-specific suggests potential therapeutic applications in autoimmune diseases, as prodigiosin delays progression in models of collagen-induced and autoimmune by modulating immune responses without broad . Recent studies from 2020-2025 have explored prodigiosin's synergies and efficacy. In with , it exhibits synergistic in and oral squamous cell carcinomas, enhancing drug influx and via increased ROS and reduced efflux, with combination indices indicating strong potentiation at sub- doses. Animal models, including xenograft studies in mice, have shown tumor regression in non-small cell and upon prodigiosin administration (doses ~10 mg/kg), with reduced tumor volumes and prolonged survival, underscoring its translational potential. As of 2025, additional research has demonstrated prodigiosin's ability to sensitize colon cancer cells () to , promoting through enhanced pathways. Furthermore, a 2024 study confirmed its against lines (, MDA-MB-231) with values of 16 μg/mL and 6.7 μg/mL, respectively, supporting ongoing exploration of its and anticancer profiles.

Applications

Pharmaceutical Uses

Prodigiosin and its derivatives have emerged as promising candidates for drug development due to their multifaceted biological activities, particularly in treating cancers, preventing transplant rejection, and combating malaria. In oncology, synthetic analogs such as obatoclax, a pan-Bcl-2 inhibitor derived from prodigiosin, have progressed to Phase I and II clinical trials for hematologic malignancies like chronic lymphocytic leukemia and solid tumors including non-small cell lung cancer, demonstrating antitumor efficacy through induction of apoptosis with limited efficacy in monotherapy but potential in combinations. These trials highlighted obatoclax's ability to enhance chemotherapy responses, though development has stalled post-Phase II without regulatory approval. For immunosuppression, prodigiosin analogs exhibit selective T-cell inhibition without broad cytotoxicity, positioning them as potential agents for to mitigate chronic rejection, with preclinical models showing synergy with drugs like cyclosporine A. In antimalarial applications, prodigiosin displays potent activity against strains, including chloroquine-resistant ones, with IC50 values ranging from 1.7 to 8.0 nM, suggesting utility in combination therapies for . Analogs like metacycloprodigiosin further support this, achieving sub-micromolar inhibition while sparing host cells. Prodigiosin's toxicity profile supports its pharmaceutical viability, with low systemic toxicity observed in (oral LD50 >10 g/kg body weight and intraperitoneal LD50 ≈4.5 g/kg in mice) and no reported for analogs in clinical evaluations. High doses may induce mild organ stress, but overall, it spares normal cells relative to cancer targets. Poor aqueous limits , prompting formulations like zein/sodium caseinate nanoparticles for oral and intravenous delivery, which enhance stability and targeted release while improving . Regulatory efforts include applications for select analogs, alongside active patents protecting anticancer derivatives, such as US Patent 10,654,801 covering prodigiosin analogs for p53-mutated tumors. These advancements underscore prodigiosin's transition from to viable therapeutic scaffold, though further optimization is needed for clinical advancement.

Industrial and Environmental Applications

Prodigiosin serves as a red pigment with applications in textiles, where it is used to dye , , , and other fabrics, providing vibrant coloration and additional properties that enhance fabric functionality. In dyeing processes, prodigiosin extracted from bacteria like or achieves high color strength (K/S values above 4) on and , with improved fastness when combined with such as Tween 80, and exhibits halochromic behavior that changes color in response to variations. These properties make it suitable for developing pH-responsive textiles, including wound dressings that swell over 100% and inhibit bacterial growth, such as against with log reductions exceeding 5. For , prodigiosin incorporation into sunscreens boosts sun protection factors by 20–65%, offering a alternative to synthetic colorants while maintaining efficacy. In the , prodigiosin is applied as a colorant in products like , , and carbonated drinks through techniques using kappa-carrageenan and , which stabilize the in spray-dried forms for even distribution and as a non-toxic option replacing synthetic azo dyes. Its ecological stems from microbial origins, reducing environmental compared to chemical dyes that contribute to and . Prodigiosin's antimicrobial and antibiofilm activities extend to environmental applications, particularly in , where it achieves up to 97.3% efficiency in eliminating bacteria like and , aiding in purification processes. It inhibits biofilm formation by pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) at concentrations as low as 1.25 mg/L, reducing by 76.24%, which supports its use in controlling microbial accumulations in water systems and industrial pipelines. Additionally, prodigiosin enables the development of coatings, including composites for that prevent spoilage, and prophylactic surfaces against biofilms in ecological settings. As an antibacterial additive, prodigiosin is incorporated into polymers like polyolefins (e.g., polyethylene) to produce colored, ecologically safe materials without the need for spraying, offering a sustainable alternative for plastic manufacturing. In agriculture, it functions as a biopesticide, exhibiting insecticidal effects against pests such as Aedes aegypti (LC50 of 14–18 µg/mL), Helicoverpa armigera, and Diaphorina citri by disrupting midgut pH and inducing oxidative stress, while also showing antifungal activity against plant pathogens like Pythium myriotylum and Rhizoctonia solani with up to 71.33% inhibition. These properties position prodigiosin as an eco-friendly tool for crop protection, leveraging low-cost production from organic wastes to minimize chemical pesticide use. The growing demand for natural pigments like prodigiosin aligns with the global natural pigments market, valued at USD 4.9 billion in 2022 and projected to reach USD 7.41 billion by 2030 at a of 5.3%, driven by consumer preferences for sustainable, non-toxic alternatives in , , and textiles. This expansion underscores prodigiosin's role in promoting by reducing reliance on synthetic dyes, which often pose health and environmental risks, while its microbial production from renewable substrates further enhances its economic viability.

References

  1. [1]
    Prodigiosin: unveiling the crimson wonder - NIH
    Jun 5, 2024 · This paper provides a systematic review of recent research on PG, covering aspects like chemical structure, bioactivity, biosynthesis, gene ...
  2. [2]
    The production and bioactivity of prodigiosin: quo vadis?
    This review provides a comprehensive summary of research undertaken toward the isolation and structural elucidation of the prodiginine family of natural ...
  3. [3]
    Etymologia: Serratia marcescens - CDC
    Sep 27, 2019 · Serratia was discovered in Italy in 1819 when it affected polenta in a small town near Padua. Bartolomeo Bizio, a Venetian pharmacist ...
  4. [4]
    Prodigiosin | SpringerLink
    Prodigiosin (C20H25N3O) is the characteristic red, water-insoluble pigment of the bacterium,Serratia marcescens. The name derives from Kraft (1902), ...
  5. [5]
    Structure, Chemical Synthesis, and Biosynthesis of Prodiginine ...
    This review provides a comprehensive overview of research undertaken toward the isolation and structural elucidation of the prodiginine family of natural ...
  6. [6]
    Serratia marcescens: The Miracle Bacillus
    ### Summary of Cultural and Religious Significance of Serratia marcescens and Prodigiosin
  7. [7]
    Science: The miraculous microbes of Bolsena | New Scientist
    Jun 4, 1994 · In the 'miracle of Bolsena', blood appeared on the sacramental bread during a mass in 13th-century Italy. But the 'blood', it turns out, was probably a culture ...Missing: significance | Show results with:significance
  8. [8]
    Miraculous Microbes: They Make Holy Statues "Bleed"--and Can Be ...
    Nov 11, 2011 · A sinister bacterium implicated in Catholic miracles and "blood"-tainted polenta also kills coral, insects, and are even are up to no good in your contact lens ...Missing: cultural significance host Bolsena<|control11|><|separator|>
  9. [9]
    PRODIGIOSIN. STRUCTURE AND PARTIAL SYNTHESIS1
    Article January 1, 1960. PRODIGIOSIN. STRUCTURE AND PARTIAL SYNTHESIS1 ... Note: In lieu of an abstract, this is the article's first page. Free first ...Missing: elucidation original
  10. [10]
    THE SYNTHESIS OF PRODIGIOSIN - ACS Publications
    Research Article October 1, 1960. THE SYNTHESIS OF PRODIGIOSIN. Click to copy ... Design and Structural Investigation of a Series of Prodigiosin and 1,10 ...Missing: original | Show results with:original<|separator|>
  11. [11]
  12. [12]
    Conditions of the Colour Change of Prodigiosin - Nature
    THERE have been several reports that prodigiosin, the pigment produced by Serratia marcescens, is red in acid solution with an absorption maximum at 535–540 ...
  13. [13]
    Application of Prodigiosin Extracts in Textile Dyeing and Novel ...
    Prodigiosin extracts from TB-G presented additional unique absorbance peaks in the spectra, at 331 and 598 nm, and higher absorbance between 200 and 242 nm.
  14. [14]
    Physical and chemical stress on Serratia marcescens and studies ...
    Mar 27, 2014 · Crude prodigiosin extracted from variant (S26) is stable at alkaline pH and its thermal stability is up to 80 °C.
  15. [15]
  16. [16]
    82-89-3(PRODIGIOSIN) Product Description - ChemicalBook
    Boiling point: 554.3±50.0 °C(Predicted) ; Density, 1.12±0.1 g/cm3(Predicted) ; storage temp. -20C ; solubility, Acetonitrile: Soluble; Ethanol: Soluble; Methanol: ...Missing: volatility | Show results with:volatility
  17. [17]
  18. [18]
  19. [19]
  20. [20]
  21. [21]
    The Serratia gene cluster encoding biosynthesis of the red antibiotic ...
    The Serratia gene cluster encoding biosynthesis of the red antibiotic, prodigiosin, shows species- and strain-dependent genome context variation · Abstract.Missing: pigA- pigN
  22. [22]
    Biosynthesis of the red antibiotic, prodigiosin, in Serratia
    Apr 7, 2005 · A bifurcated pathway has been proposed for the biosynthesis of prodigiosin culminating in the enzymic condensation of the terminal products of ...
  23. [23]
    Analysis of the prodiginine biosynthesis gene cluster of ...
    Recently, a gene cluster in Streptomyces coelicolor encoding the biosynthesis of undecylprodiginine and butyl-meta-cycloheptylprodiginine has been sequenced.
  24. [24]
    luxS mutants of Serratia defective in autoinducer-2-dependent ...
    The enzyme LuxS is responsible for the production of autoinducer-2 (AI-2), a molecule that has been implicated in quorum sensing in many bacterial species.
  25. [25]
    Biosynthesis and Bioactivity of Prodiginine Analogs in Marine ...
    This review will summarize prodiginine biosynthesis, bioactivity, and gene regulation in Pseudoalteromonas in comparison to the previously characterized ...Missing: transaminase | Show results with:transaminase
  26. [26]
    The chemistry of vicinal tricarbonyls a total synthesis of prodigiosin
    The addition of primary amines to alkenyl vicinal tricarbonyls leads to 5-substituted-3-hydroxypyrroles. This reaction has been employed in a synthesis of ...
  27. [27]
    Prodigiosin - an overview | ScienceDirect Topics
    First isolated in the 1930s69 from microorganisms, including Serratia and Streptomyces,70 these red pigments and their semisynthetic tripyrrolic analogs ...
  28. [28]
    Prodigiosin Production by Serratia marcescens UCP 1549 Using ...
    Prodigiosin (5[(3-methoxy-5-pyrrol-2-ylidene-pyrrol-2-ylidene)-methyl]-2-methyl-3-pentyl-1H- pyrrole) is a secondary metabolite alkaloid with a unique ...Missing: primary | Show results with:primary<|control11|><|separator|>
  29. [29]
    Optimization of prodigiosin production by Serratia marcescens using ...
    Apr 18, 2017 · At temperatures over ≥30 °C, Serratia marcescens stops producing pigment and colonies appear in a creamy white color, above that temperature ...
  30. [30]
    Prodigiosin: a promising biomolecule with many potential ...
    Prodigiosin (PG) is an alkaloid red bio-dye produced by diverse microorganisms and composed of a linear tripyrrole chemical structure.
  31. [31]
    Optimization of prodigiosin biosynthesis by Serratia marcescens ...
    Jul 9, 2020 · The present study screened waste and unconventional bioresources for the production of prodigiosin using S. marcescens ATCC 13880.
  32. [32]
    Improving prodigiosin production by transcription factor engineering ...
    In this study, transcription factor engineering and promoter engineering was used to promote the production of prodigiosin in S. marcescens JNB5-1.
  33. [33]
    Improving Bioprocess Conditions for the Production of Prodigiosin ...
    Mar 23, 2024 · The conditions allowing the highest bacterial cell growth and prodigiosin production were also tested with another marine strain: S. marcescens ...
  34. [34]
    Sulfate as a pivotal factor in regulation of Serratia sp. strain S2B ...
    In conclusion, a newly isolated Serratia sp. strain S2B, with suitable capacity to produce prodigiosin metabolite in a cost-effective medium–sugar beet molasses ...
  35. [35]
    Transcriptomic analysis of cell envelope inhibition by prodigiosin in ...
    Jan 22, 2024 · This study identified a significant antibacterial effect of prodigiosin against MRSA with a minimum inhibitory concentration as low as 2.5 mg/L.
  36. [36]
    Antimicrobial activity of prodigiosin is attributable to plasma ...
    Prodigiosin was highly inhibitory (30% growth rate reduction of C. albicans, E. coli, S. aureus at 0.3, 100 and 0.18 μg ml-1, respectively); caused leakage of ...Missing: IC50 | Show results with:IC50
  37. [37]
    Antimalarial activity of natural and synthetic prodiginines - PubMed
    Aug 11, 2011 · Herein we describe the in vitro antimalarial activity of four natural (IC(50) = 1.7-8.0 nM) and three sets of synthetic prodiginines against Plasmodium ...Missing: IC50 | Show results with:IC50
  38. [38]
    Prodigiosins as a New Group of H+/Cl−Symporters That Uncouple ...
    Prodigiosins may prove useful for the clarification of ion transport mechanisms. What is the mechanism of H+/Cl− symport (or OH−/Cl− antiport) of prodigiosins?
  39. [39]
    Transcriptomic analysis of the antimicrobial activity of prodigiosin ...
    Oct 13, 2023 · In this study, the antibacterial activity of prodigiosin against skin microorganisms was explored. Paper disc assay on skin bacterial cells ...<|control11|><|separator|>
  40. [40]
    Prodigiosin inhibits bacterial growth and virulence factors as a ...
    Jun 23, 2021 · Prodigiosin was first extracted from S. marcescens and its purity confirmed by absorption spectrum, high performance liquid chromatography ...
  41. [41]
    Prodigiosin inhibits Wnt/β-catenin signaling and exerts ... - PNAS
    Oct 31, 2016 · These results indicate that prodigiosin can inhibit proliferation and induce apoptosis in breast cancer cells. Fig. S3. Open in ViewerMissing: IC50 | Show results with:IC50
  42. [42]
    Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in ...
    This is a multi-center, open-label, Phase I/II study of obatoclax administered in combination with docetaxel in 3-week cycles to patients with relapsed or ...Missing: 2023 | Show results with:2023
  43. [43]
    Bcl-2 inhibition in the treatment of hematologic malignancies
    Dec 3, 2023 · Navitoclax has been evaluated in phase I and II clinical trials and has clinical activity in small cell lung cancer and acute lymphoblastic ...
  44. [44]
    Rise of the natural red pigment 'prodigiosin' as an immunomodulator ...
    Dec 28, 2022 · Prodigiosin, a red pigment produced by Serratia marcescens, possesses inherent anticancer characteristics, showing interesting antitumour activities in ...Missing: regression 2020-2024
  45. [45]
    Antimalarial Activity of Natural and Synthetic Prodiginines
    Prodiginines are a family of linear and cyclic oligopyrrole red-pigmented compounds. Herein we describe the in vitro antimalarial activity of four natural ...<|separator|>
  46. [46]
    Potent In Vitro Antimalarial Activity of Metacycloprodigiosin Isolated ...
    Metacycloprodigiosin exhibited potent in vitro activity against Plasmodiumfalciparum K1, with a 50% inhibitory concentration of 0.0050 ± 0.0010 μg/ml, while ...
  47. [47]
    Assessment of Acute Toxicity and Lethal Dose of Prodigosin in Mice
    Results: The results of this study indicated that LD50 for prodigiosin is 4500 mg / kg, when administered intraperitoneally and histopathological findings ...Missing: rodents | Show results with:rodents
  48. [48]
    Experimental Study of Acute Oral Toxicity and Genetic Toxicity of ...
    The results showed that acute oral medial lethal dose (LD50) of prodigiosin was greater than 10 g/kg BW. All three genetic toxicity tests gave negative results.Missing: rodents | Show results with:rodents
  49. [49]
    Prodigiosin: a promising biomolecule with many potential ...
    Prodigiosin (PG) is an alkaloid red bio-dye produced by diverse microorganisms and composed of a linear tripyrrole chemical structure. PG emerges as a really ...
  50. [50]
    Prodigiosin/celecoxib-loaded into zein/sodium caseinate ... - Nature
    Jan 2, 2024 · It was isolated from Serratia species for the first time by Kraft 1902. PDG has four possible anticancer mechanisms as it can cause (1) ...<|control11|><|separator|>
  51. [51]
    US10654801B2 - Prodigiosin analogs - Google Patents
    Embodiments of the present disclosure include prodigiosin analogs which have anti-cancer activity against tumors with mutated p53 proteins. Without ...
  52. [52]
    Prodigiosin and its potential applications - PMC - PubMed Central
    The structure of prodigiosin, the archetypal prodiginine, was elucidated in the early 1960s by partial and total chemical synthesis revealing a pyrrolyl ...
  53. [53]
    Transcriptomic analysis of cell envelope inhibition by prodigiosin in ...
    Jan 21, 2024 · At a prodigiosin concentration of 1.25 mg/L, biofilm formation was inhibited by 76.24%, while 2.5 mg/L prodigiosin significantly reduced the ...Missing: bioremediation | Show results with:bioremediation
  54. [54]
    Application of prodigiosin as a colorant for polyolefines
    This novel elaborated stage is necessary for thermostability a dye in polymer. The consumption of prodigiosin preparation is more economical in the technology ...
  55. [55]
    A Potential Eco-Friendly Insecticide for Sustainable Crop Protection
    Prodigiosin synthesis typically occurs in cells grown aerobically at temperatures up to 32 °C. Nutritional factors, such as phosphate limitation and glucose ...Prodigiosin: A Potential... · 1. Introduction · 2.1. Production Conditions
  56. [56]
    (PDF) Recent Advances in Eco-Friendly and Scaling-Up ...
    Dec 5, 2022 · Prodigiosin (PG) is a potential red pigment mainly produced from microbes (mainly from Serratia marcescens) that has attracted much research ...
  57. [57]
    Natural Pigments Market | Size, Share, Growth | 2023 - 2030
    The Global Natural Pigments Market was estimated to be worth USD 4.9 Billion in 2022 and is anticipated to reach a value of USD 7.41 Billion by 2030, growing ...Missing: prodigiosin | Show results with:prodigiosin